Role of Ormeloxifene in Treatment of Abnormal Uterine Bleeding (AUB) In Comparison with Other Hormanal Treatment Modalities

Abstract

Introduction: Abnormal uterine bleeding (AUB) is state of abnormal bleeding from uterus without any clinically detectable organic, systemic and iatrogenic causes. AUB is major and one of the most distressing gynaecological problems for both patient and clinician. Aims and objective- To compare the effect of ormeloxifene for treatment of AUB and its comparison with Norethisterone and oral contraceptives in different age groups in view of efficacy, compliance, complication and follow-up in terms of avoiding hysterectomies. Material and Methods: 300 cases of AUB were divided into three groups during study period September 2016 to September 2017. Group A (n=100) were given ormeloxifene to received 60 mg twice weekly for 12 week followed by once weekly for 3 months. Group B (n=100) were given Norethisterone 10 mg bd in every cycle from day 5 to day 25 for 6 month and Group C were given oral contraceptive pills (OCP) from day 1 to day 21 of menstrual cycle for six cycle. Results: There is significant reduction of PBAC score from 127 to 36 after six month of treatment in group A, 127 to 77 in group B whereas 128 to 96 in group C. Mean pre-treatment endometrial thickness decreased markedly in ormeloxifene group from 9.8 mm to 5.8 mm as compared to norethisterone (9.7-6.4mm) and OCP group (9.7-7.7mm).Complications such as hypo amenorrhea 73% patient and about 15% develop amenorrhea. Conclusion: Ormeloxifene has better compliance and acceptability with marked relief of symptoms. Women who underwent hysterectomy after treatment were also significantly less in ormeloxifene group. Hence, ormeloxifene should be considered the first choice in management of AUB especially in perimenopausal age group where amenorrhea is acceptable.

Authors and Affiliations

Dr. Himanshi Gupta

Keywords

Related Articles

Study of Serum Lipid Profile in Beta-Thalassemia Major Patients

Background: Beta-thalassemia is the commonest single-gene disorder in the Indian population. Beta thalassemia major is caused by complete absence of beta globin chain production resulting from reduced synthesis of one or...

Formulation and In vivo Evaluation of sustained release pellets of bosentan by pan coating process

The aim of the present study was to develop sustained release pellets of bosentan with eudragit RL 100 as rate retarding polymer by pan coating process. The prepared pellets were evaluated for drug content, particle size...

Study on the Prevalence of Overweight and Obesity among Medical Students of CAIMS Karimnagar, Telangana

Background: Overweight and Obesity is one of the causes of Death. The morbidity associated with overweight and obesity is also enormous. Prevalence of overweight and obesity is increasing worldwide. Objective: To study...

Evaluation of Antiulcer Activity of Abelmoschus Esculentus in Laboratory Animals.

The objective of present study is to evaluate the anti ulcer activity of methanolic extract of seeds of Abelmoschus esculentus. The cause of ulceration in patients is mainly due to hypersecretion of ga...

Relevance of Position of Surgically Important Mental Foramen in Human Mandibles of Vindhya Region

Objective: To contribute the database of location and mapping of mental foramina of human mandibles in Vindhya region of Madhya Pradesh. Design: Prospective Cross-sectional study Material & methods: Study was carried ou...

Download PDF file
  • EP ID EP495693
  • DOI -
  • Views 136
  • Downloads 0

How To Cite

Dr. Himanshi Gupta (2018). Role of Ormeloxifene in Treatment of Abnormal Uterine Bleeding (AUB) In Comparison with Other Hormanal Treatment Modalities. International Journal of Medical Science and Innovative Research (IJMSIR), 3(1), 346-352. https://europub.co.uk/articles/-A-495693